Skip to main content
Tavish Nanda, MD, Ophthalmology, Hartford, CT

Tavish Nanda MD

Retinal Disease, Uveitis, Ocular Oncology


Vitreoretinal Surgeon

Join to View Full Profile
  • 43 Woodland StHartford, CT 06105

Dr. Nanda is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Tavish Nanda is a vitreoretinal specialist in Hartford, CT. He received his medical degree from Columbia University Vagelos College of Physicians and Surgeons. Dr. Nanda completed residency training at Columbia University in New York City, where he served as chief resident, followed by a two-year combined vitreoretinal surgery fellowship with the renowned New England Eye Center / Ophthalmic Consultants of Boston program.

    He specializes in retinal disease, uveitis, and ocular oncology and has experience with complex surgical conditions from tractional detachments to secondary IOLs. He is board certified in ophthalmology, and has been active on the national and international level, with more than 50 publications and presentations. During fellowship he also served as a sub-investigator for over two dozen clinical trials, including Vabysmo and Syfovre.

Education & Training

  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Residency, Ophthalmology, 2018 - 2021
  • Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and SurgeonsClass of 2017

Certifications & Licensure

  • CT State Medical License
    CT State Medical License 2023 - 2025
  • MA State Medical License
    MA State Medical License 2021 - 2025
  • Ophthalmology
    American Board of Ophthalmology Ophthalmology

Publications & Presentations

PubMed

Press Mentions

  • More Than a Third of Inpatients Don't Receive Their Anti-Glaucoma Drugs
    More Than a Third of Inpatients Don't Receive Their Anti-Glaucoma DrugsJuly 12th, 2019

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: